Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UNIFORM: BOW015 vs Remicade in RA
NCT02683564Phase 3Unknown
- Sponsor
- EPIRUS Biopharmaceuticals, Inc.
- Start
- Feb 2016
- Primary completion
- Jul 2017
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of infliximab-epirus in rheumatoid arthritis (RA), sponsored by EPIRUS Biopharmaceuticals, Inc.. Status: unknown.
02
Drugs
infliximab-epirus
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02683564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02683564.